NCT06099912 Individualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With NDMM Status RECRUITING Phase N/A
NCT06087653 Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM) Status RECRUITING Phase PHASE1/PHASE2
NCT06083922 A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS) Status RECRUITING Phase PHASE2
NCT06083207 A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma Status RECRUITING Phase PHASE1/PHASE2
NCT06082284 A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method. Status RECRUITING Phase N/A
NCT06073353 Psychosocial Mobile Application (THRIVE-M) for Patients With Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase NA
NCT06069024 Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide Status COMPLETED Phase N/A
NCT06067581 the Safety and Efficacy of SENL103 Autologous T Cell Injection Status UNKNOWN Phase EARLY_PHASE1
NCT06066346 A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy Status RECRUITING Phase PHASE2
NCT06063603 Evaluation of a Pain Management Intervention Preparatory to a Future Pragmatic Trial, ASCENT Study Status COMPLETED Phase NA
NCT06062537 Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple Myeloma Patients Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06060080 Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma Status UNKNOWN Phase NA
NCT06057402 Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM) Status RECRUITING Phase PHASE4
NCT06055894 A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS) Status RECRUITING Phase NA
NCT06052826 Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study Status RECRUITING Phase PHASE2
NCT06048250 Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma Status RECRUITING Phase PHASE1
NCT06045806 A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06045091 To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL Status RECRUITING Phase EARLY_PHASE1